JP2014209117A - Color particles for immunochromato, and immunochromato reagent for diagnosis using the same - Google Patents
Color particles for immunochromato, and immunochromato reagent for diagnosis using the same Download PDFInfo
- Publication number
- JP2014209117A JP2014209117A JP2014072583A JP2014072583A JP2014209117A JP 2014209117 A JP2014209117 A JP 2014209117A JP 2014072583 A JP2014072583 A JP 2014072583A JP 2014072583 A JP2014072583 A JP 2014072583A JP 2014209117 A JP2014209117 A JP 2014209117A
- Authority
- JP
- Japan
- Prior art keywords
- particles
- colored particles
- immunochromatography
- colored
- conjugated compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title claims abstract description 146
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 18
- 238000003745 diagnosis Methods 0.000 title abstract description 3
- 239000010419 fine particle Substances 0.000 claims abstract description 37
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- 229920000642 polymer Polymers 0.000 claims abstract description 28
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 22
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 22
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 22
- 238000003317 immunochromatography Methods 0.000 claims description 40
- 239000000178 monomer Substances 0.000 claims description 29
- 229920000128 polypyrrole Polymers 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 7
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000000691 measurement method Methods 0.000 claims description 5
- -1 methacryloyl group Chemical group 0.000 claims description 5
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 4
- 229920001197 polyacetylene Polymers 0.000 claims description 3
- 229920000767 polyaniline Polymers 0.000 claims description 3
- 229920000414 polyfuran Polymers 0.000 claims description 3
- 229920000123 polythiophene Polymers 0.000 claims description 3
- 150000008054 sulfonate salts Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 16
- 239000004816 latex Substances 0.000 abstract description 11
- 229920000126 latex Polymers 0.000 abstract description 11
- 239000000126 substance Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 12
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 238000001514 detection method Methods 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 229940048053 acrylate Drugs 0.000 description 9
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 6
- 230000000379 polymerizing effect Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 208000037797 influenza A Diseases 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000008105 immune reaction Effects 0.000 description 4
- 239000003505 polymerization initiator Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000010556 emulsion polymerization method Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 239000011147 inorganic material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- MNCGMVDMOKPCSQ-UHFFFAOYSA-M sodium;2-phenylethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=CC1=CC=CC=C1 MNCGMVDMOKPCSQ-UHFFFAOYSA-M 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- RKMJXTWHATWGNX-UHFFFAOYSA-N decyltrimethylammonium ion Chemical compound CCCCCCCCCC[N+](C)(C)C RKMJXTWHATWGNX-UHFFFAOYSA-N 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- ZKIAYSOOCAKOJR-UHFFFAOYSA-M lithium;2-phenylethenesulfonate Chemical compound [Li+].[O-]S(=O)(=O)C=CC1=CC=CC=C1 ZKIAYSOOCAKOJR-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- QIFCIFLDTQJGHQ-UHFFFAOYSA-M potassium;2-phenylethenesulfonate Chemical compound [K+].[O-]S(=O)(=O)C=CC1=CC=CC=C1 QIFCIFLDTQJGHQ-UHFFFAOYSA-M 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
本発明は、診断用イムノクロマト試薬に好適に使用されるイムノクロマト用着色粒子と、該着色粒子を用いた診断用イムノクロマト試薬に関する。 The present invention relates to an immunochromatographic colored particle suitably used for a diagnostic immunochromatographic reagent, and a diagnostic immunochromatographic reagent using the colored particle.
従来より、種々の疾患の診断を目的として、被検物質に免疫学的に結合する物質とクロマトグラフィーの原理を組み合わせて被検物質を目視判定で検出する診断用イムノクロマト試薬が広く用いられている。診断用イムノクロマト試薬は、被検物質である抗原(または抗体)に対する抗体(または抗原)をクロマトグラフ媒体に固定化して、免疫反応部位を作製したものを固定相とし、上記被検物質と結合可能な抗体(または抗原)によって感作された検出用担体と被検物質を含んだ検体とを接触させて抗原抗体複合体を形成させ、それらが含有された液体を移動相とした免疫クロマトグラフの測定方法に用いられる。 Conventionally, for the purpose of diagnosing various diseases, a diagnostic immunochromatographic reagent for detecting a test substance by visual judgment by combining a substance that immunologically binds to the test substance and a chromatography principle has been widely used. . The immunochromatographic reagent for diagnosis can be bound to the above test substance by immobilizing an antibody (or antigen) against the test substance antigen (or antibody) on a chromatographic medium and creating an immune reaction site as a stationary phase. Of an immunochromatograph using a detection carrier sensitized by a specific antibody (or antigen) and a specimen containing a test substance to form an antigen-antibody complex and using the liquid containing them as a mobile phase Used in measurement methods.
当該測定方法において、検出用担体と接触した被検物質を含んだ検体は、免疫反応を行い、検出用粒子−感作に用いられた抗体(または感作に用いられた抗原)−検体中の抗原(または抗体)とからなる複合体が生成する。この複合体がクロマトグラフ上の反応部位まで達すると、再度免疫反応を行い、前記複合体が前記固定化抗体(または固定化抗原)に結合されて、検出用担体が捕捉される為、その捕捉の有無を目視判定することにより検体中の被検物質の存在を判定することができる(当該測定方法をイムノクロマトグラフ法という。)。 In the measurement method, a specimen containing a test substance in contact with a detection carrier undergoes an immune reaction, and the detection particles—the antibody used for sensitization (or the antigen used for sensitization) —in the specimen A complex consisting of an antigen (or antibody) is produced. When this complex reaches the reaction site on the chromatograph, an immune reaction is performed again, the complex is bound to the immobilized antibody (or immobilized antigen), and the detection carrier is captured. The presence or absence of the test substance in the sample can be determined by visually determining the presence or absence of this (the measurement method is referred to as an immunochromatography method).
上記イムノクロマトグラフ法では、目視判定を容易にするために、検出用担体に着色された微粒子が広く利用されている。このような検出用担体としては、その粒径や調製条件によって自然呈色するコロイド状金属粒子もしくはコロイド状金属酸化物粒子などのコロイド状粒子や、合成高分子よりなるラテックス粒子を着色することによって得られる着色ラテックス粒子、着色剤とともに単量体を重合して得られる着色ラテックス粒子などが用いられている。しかしながら、上記コロイド状粒子は、その粒径及び調製条件によって色調が決定されてしまうため、所望の色に調製できない、また鮮明な濃い色調のものを得にくい等の問題点があった。一方、着色ラテックス粒子は、色調を自由に選択できる点で有利であるが、着色量を高める、つまりは濃い色調を得ることが難しく、イムノクロマトに用いた際に目視判定がしにくい等の問題点があった。 In the immunochromatography method, fine particles colored on a detection carrier are widely used to facilitate visual determination. As such a detection carrier, colloidal particles such as colloidal metal particles or colloidal metal oxide particles that naturally color depending on the particle size or preparation conditions, or latex particles made of a synthetic polymer are colored. Colored latex particles obtained by polymerizing monomers together with the obtained colored latex particles and colorants are used. However, since the color tone of the colloidal particles is determined depending on the particle size and the preparation conditions, there are problems such that it is impossible to prepare a desired color and it is difficult to obtain a clear dark color tone. On the other hand, colored latex particles are advantageous in that the color tone can be freely selected, but there are problems such as increasing the amount of coloration, that is, it is difficult to obtain a dark color tone, and visual judgment is difficult when used in immunochromatography. was there.
この問題を解決する為に、特許文献1では、着色ラテックス粒子中の着色剤の含有率が10重量%以上とする方法が示されており、目視判定性を向上させている。しかし、この方法でも、まだ十分な感度が確保されているとは言えず、更に着色量を高めると、色素等がラテックス粒子の表面を覆うようになり、粒子本来の表面状態が損なわれる結果、非特異反応や過凝集による目詰まりなどを引き起こすことが問題となっていた。 In order to solve this problem, Patent Document 1 discloses a method in which the content of the colorant in the colored latex particles is 10% by weight or more, and the visual judgment is improved. However, even with this method, it can not be said that sufficient sensitivity is still secured, and when the amount of coloring is further increased, the pigment and the like come to cover the surface of the latex particles, resulting in damage to the original surface state of the particles, It has been a problem to cause clogging due to non-specific reaction or excessive aggregation.
そこで、更なる目視判定性の向上を達成しつつ、非特異反応や過凝集による目詰まり等を生じない検出用担体、つまりは検出用担体の濃色化及びラテックス粒子の表面状態の維持が望まれていた。
本発明は、上記事情に鑑みてなされたもので、表面を形成する組成自身が着色性を示し、ラテックス粒子の表面組成が維持されており濃い色調を示すことができるイムノクロマト用着色粒子と、該着色粒子を用いた診断用イムノクロマト試薬を提供することを課題とする。
Therefore, it is hoped that the detection carrier that does not cause clogging due to non-specific reaction or overaggregation, that is, the detection carrier is darkened and the surface state of the latex particles is maintained while further improving visual judgment. It was rare.
The present invention has been made in view of the above circumstances, and the colored particles for immunochromatography capable of exhibiting a dark color tone while maintaining the surface composition of the latex particles while the surface forming composition itself exhibits colorability, It is an object of the present invention to provide a diagnostic immunochromatographic reagent using colored particles.
本発明は、以下に関する。
<発明1>
表面を構成する成分としてπ共役化合物を含む高分子を含有することを特徴とするイムノクロマト用着色粒子。
<発明2>
前記着色粒子の平均粒径が50〜1000nmであることを特徴とする発明1に記載のイムノクロマト用着色粒子。
<発明3>
炭化水素系微粒子の表面にπ共役化合物を含む高分子を被覆させたことを特徴とする発明1または2に記載のイムノクロマト用着色粒子。
<発明4>
π共役化合物を含む高分子が、ポリアセチレン、ポリアニリン、ポリフラン、ポリピロール、ポリチオフェンからなる群から選ばれる少なくとも一種類以上であることを特徴とする発明1〜3のいずれか1項に記載のイムノクロマト用着色粒子。
<発明5>
炭化水素系微粒子が、
(1)フェニル基を有する重合性単量体、メタクリロイル基を有する重合性単量体、アクリロイル基を有する重合性単量体からなる群から選ばれる一種以上の重合性単量体と、
(2)フェニル基及びスルホン酸塩を有する重合性単量体を共重合させたことを特徴とする発明3または4に記載のイムノクロマト用着色粒子。
<発明6>
炭化水素系微粒子の表面にπ共役化合物を含む高分子を被覆させる際に、スルホン酸塩を有する重合性単量体を存在させることを特徴とする発明3〜5のいずれか1項に記載のイムノクロマト用着色粒子。
<発明7>
前記着色粒子が黒色粒子であることを特徴とする発明1〜6のいずれか1項に記載のイムノクロマト用着色粒子。
<発明8>
発明1〜7のいずれか1項に記載のイムノクロマト用着色粒子を用いたことを特徴とする診断用イムノクロマト試薬。
<発明9>
発明8に記載のイムノクロマト試薬を用いたことを特徴とするイムノクロマト測定方法。
The present invention relates to the following.
<Invention 1>
A colored particle for immunochromatography, comprising a polymer containing a π-conjugated compound as a component constituting the surface.
<Invention 2>
The colored particles for immunochromatography according to invention 1, wherein the colored particles have an average particle size of 50 to 1000 nm.
<Invention 3>
The colored particles for immunochromatography according to invention 1 or 2, wherein the surface of the hydrocarbon fine particles is coated with a polymer containing a π-conjugated compound.
<Invention 4>
The coloring for immunochromatography according to any one of inventions 1 to 3, wherein the polymer containing a π-conjugated compound is at least one selected from the group consisting of polyacetylene, polyaniline, polyfuran, polypyrrole, and polythiophene. particle.
<Invention 5>
Hydrocarbon fine particles
(1) one or more polymerizable monomers selected from the group consisting of a polymerizable monomer having a phenyl group, a polymerizable monomer having a methacryloyl group, and a polymerizable monomer having an acryloyl group;
(2) The colored particles for immunochromatography according to invention 3 or 4, wherein a polymerizable monomer having a phenyl group and a sulfonate is copolymerized.
<Invention 6>
The invention according to any one of inventions 3 to 5, wherein a polymerizable monomer having a sulfonate salt is present when the surface of the hydrocarbon fine particles is coated with a polymer containing a π-conjugated compound. Colored particles for immunochromatography.
<Invention 7>
The colored particles for immunochromatography according to any one of inventions 1 to 6, wherein the colored particles are black particles.
<Invention 8>
A diagnostic immunochromatographic reagent using the colored particles for immunochromatography according to any one of inventions 1 to 7.
<Invention 9>
An immunochromatographic measurement method using the immunochromatographic reagent according to invention 8.
本発明によれば、粒子表面を形成する組成自身が着色性を示すことで、ラテックス粒子の表面組成を維持し、濃い色調を示すことができるイムノクロマト用着色粒子が得られるため、従来より濃色化が図れる視認性の優れたイムノクロマト用着色粒子、及び該着色粒子を用いた診断用イムノクロマト試薬を提供できる。 According to the present invention, colored particles for immunochromatography that can maintain the surface composition of latex particles and can exhibit a deep color tone are obtained because the composition itself that forms the particle surface exhibits colorability. It is possible to provide immunochromatographic colored particles with excellent visibility that can be converted to a large amount, and diagnostic immunochromatographic reagents using the colored particles.
以下、本発明のイムノクロマト用着色粒子について詳細に説明する。
本発明のイムノクロマト用着色粒子は、表面を構成する成分としてπ共役化合物を含む高分子を含有する着色粒子である。なかでも炭化水素系微粒子の表面にπ共役化合物を含む高分子を被覆させた着色粒子である。これらは、イムノクロマト用の検出用担体として好適に用いられる。
Hereinafter, the colored particles for immunochromatography of the present invention will be described in detail.
The colored particles for immunochromatography of the present invention are colored particles containing a polymer containing a π-conjugated compound as a component constituting the surface. Among these, colored particles are obtained by coating the surface of hydrocarbon-based fine particles with a polymer containing a π-conjugated compound. These are suitably used as detection carriers for immunochromatography.
上記炭化水素系微粒子は、
(1)フェニル基を有する重合性単量体、メタクリロイル基を有する重合性単量体、アクリロイル基を有する重合性単量体からなる群から選ばれる一種類以上の重合性単量体と、
(2)フェニル基及びスルホン酸塩を有する重合性単量体
を共重合させた粒子であれば特に限定されず、従来より免疫測定分野で用いられてきた粒子を用いることができる。
The hydrocarbon fine particles are
(1) one or more polymerizable monomers selected from the group consisting of a polymerizable monomer having a phenyl group, a polymerizable monomer having a methacryloyl group, and a polymerizable monomer having an acryloyl group;
(2) There is no particular limitation as long as it is a particle obtained by copolymerizing a polymerizable monomer having a phenyl group and a sulfonate, and particles conventionally used in the field of immunoassay can be used.
フェニル基を有する重合性単量体としては、例えば、スチレン、クロルスチレン、α−メチルスチレン、ビニルトルエンなどの重合性不飽和芳香族類が挙げられる。また、ジビニルベンゼン等の架橋性単量体も含まれ、適量を存在させても構わない。メタクリロイル基またはアクリロイル基を有する重合性単量体としては、例えば、(メタ)アクリル酸メチル、(メタ)アクリル酸エチル、(メタ)アクリル酸エチルn-プロピル、(メタ)アクリル酸−2ヒドロキシエチル、(メタ)アクリル酸グリシジル等の重合性不飽和カルボン酸エステル類、(メタ)アクリル酸、イタコン酸、マレイン酸、フマル酸などの重合性不飽和カルボン酸類、またこれらの塩類、例えば、(メタ)アクリル酸ナトリウム、(メタ)アクリル酸カリウム、(メタ)アクリルアミド、N−メチロール(メタ)アクリルアミド、N,N−ジメチル(メタ)アクリレート等の重合性不飽和カルボン酸アミド類が挙げられる。また、エチレングリコール(メタ)アクリレートやプロピレングリコール(メタ)アクリレート、メチレンビス(メタ)アクリルアミド等の架橋性単量体も含まれ、適量を存在させても構わない。これらの単量体は、1種または2種以上を混合して使用することができる。 Examples of the polymerizable monomer having a phenyl group include polymerizable unsaturated aromatics such as styrene, chlorostyrene, α-methylstyrene, and vinyltoluene. Further, a crosslinkable monomer such as divinylbenzene is also included, and an appropriate amount may be present. Examples of the polymerizable monomer having a methacryloyl group or an acryloyl group include, for example, methyl (meth) acrylate, ethyl (meth) acrylate, n-propyl (meth) acrylate, and 2-hydroxyethyl (meth) acrylate. Polymerizable unsaturated carboxylic acid esters such as glycidyl (meth) acrylate, polymerizable unsaturated carboxylic acids such as (meth) acrylic acid, itaconic acid, maleic acid and fumaric acid, and salts thereof such as (meta ) Polymerizable unsaturated carboxylic acid amides such as sodium acrylate, potassium (meth) acrylate, (meth) acrylamide, N-methylol (meth) acrylamide, N, N-dimethyl (meth) acrylate and the like. Moreover, crosslinkable monomers, such as ethylene glycol (meth) acrylate, propylene glycol (meth) acrylate, and methylene bis (meth) acrylamide, are also included, and an appropriate amount may be present. These monomers can be used alone or in combination of two or more.
フェニル基及びスルホン酸塩を有する重合性単量体としては、例えば、スチレンスルホン酸ナトリウム、スチレンスルホン酸カリウム、スチレンスルホン酸リチウム等が挙げられる。 Examples of the polymerizable monomer having a phenyl group and a sulfonate include sodium styrenesulfonate, potassium styrenesulfonate, lithium styrenesulfonate, and the like.
これらのうち、特にスチレンとスチレンスルホン酸ナトリウムからなる共重合体、及びスチレンとメタクリル酸メチル及びスチレンスルホン酸ナトリウムからなる共重合体が好ましい。 Among these, a copolymer composed of styrene and sodium styrenesulfonate, and a copolymer composed of styrene, methyl methacrylate and sodium styrenesulfonate are particularly preferable.
上記共重合体の重合方法としては、従来より公知の重合方法を用いることができ、分散重合法、懸濁重合法、乳化重合法、ソープフリー乳化重合法が挙げられるが、ソープフリー乳化重合法が好ましい。ソープフリー乳化重合法としては、例えば、特開2003−510956号公報等に記載の方法を用いることができる。 As the polymerization method of the copolymer, conventionally known polymerization methods can be used, and examples thereof include a dispersion polymerization method, a suspension polymerization method, an emulsion polymerization method, and a soap-free emulsion polymerization method. Is preferred. As the soap-free emulsion polymerization method, for example, a method described in JP-A No. 2003-51095 can be used.
本発明は、表面を構成する成分としてπ共役化合物を含む高分子が含有されていることを特徴としている。尚、π共役化合物を含む高分子によって被覆される炭化水素系微粒子について前述したが、この炭化水素系微粒子が存在しない、すなわち、π共役化合物を含む高分子微粒子をπ共役化合物を含む高分子で被覆したイムノクロマト用着色粒子も本発明に含まれるのは言うまでもない。 The present invention is characterized in that a polymer containing a π-conjugated compound is contained as a component constituting the surface. The hydrocarbon fine particles coated with the polymer containing the π-conjugated compound have been described above. However, the hydrocarbon fine particles do not exist, that is, the polymer fine particles containing the π-conjugated compound are made of a polymer containing the π-conjugated compound. Needless to say, the coated colored particles for immunochromatography are also included in the present invention.
また、π共役化合物を含む高分子は、着色粒子の表面を構成する成分中に主成分として存在していればよい。表面にπ共役化合物を主成分として含む場合には、該着色粒子は黒色を呈し、黒色着色粒子として好適に用いられる。ここで主成分とは全体の70質量%以上である成分を意味する。主成分(π共役系化合物)以外の成分としては、チタンブラック、酸化鉄等の黒色無機材料が挙げられ、例えば本発明のイムノクロマト用着色粒子の表面は、π共役系化合物とともにこれらの黒色無機材料を30質量%以下の範囲で含有する組成物から形成されていてもよい。その場合、重合または重縮合によりπ共役化合物を含む高分子を合成する際などに、これらの黒色無機材料を共存させればよい。また、上記組成物には、主成分であるπ共役系化合物の他に、黒色粒子の黒色に影響を与えない範囲で、π共役系化合物以外のポリマーなどが含まれてもよい。 Further, the polymer containing the π-conjugated compound may be present as a main component in the components constituting the surface of the colored particles. When the surface includes a π-conjugated compound as a main component, the colored particles exhibit a black color and are preferably used as black colored particles. Here, the main component means a component that is 70% by mass or more of the whole. Examples of components other than the main component (π-conjugated compound) include black inorganic materials such as titanium black and iron oxide. For example, the surface of the colored particles for immunochromatography of the present invention, together with the π-conjugated compound, contains these black inorganic materials. May be formed from the composition which contains 30 mass% or less. In that case, these black inorganic materials may be allowed to coexist when a polymer containing a π-conjugated compound is synthesized by polymerization or polycondensation. In addition to the π-conjugated compound as the main component, the composition may contain a polymer other than the π-conjugated compound as long as it does not affect the black color of the black particles.
π共役化合物を含む高分子とは、π共役化合物を含む高分子を形成し得る単量体を用いて製造された重合体であり、このような単量体(以下、π共役形成性単量体という場合がある。)としては、アセチレン、アニリン、フラン、ピロール、チオフェン及びこれらの誘導体が挙げられ、これらのうち1種以上を使用できる。 A polymer containing a π-conjugated compound is a polymer produced using a monomer capable of forming a polymer containing a π-conjugated compound. Such a monomer (hereinafter referred to as π-conjugated-forming monomer) Examples of the body include acetylene, aniline, furan, pyrrole, thiophene, and derivatives thereof, and one or more of these can be used.
π共役化合物を含む高分子の具体例としては、アセチレン及びその誘導体を重合して得られるポリアセチレン、アニリン及びその誘導体を重合して得られるポリアニリン、フラン及びその誘導体を重合して得られるポリフラン、ピロール及びその誘導体を重合して得られるポリピロール、チオフェン及びその誘導体を重合して得られるポリチオフェンが挙げられ、これらのなかではポリピロールが好ましい。 Specific examples of the polymer containing a π-conjugated compound include polyacetylene obtained by polymerizing acetylene and derivatives thereof, polyaniline obtained by polymerizing aniline and derivatives thereof, polyfuran obtained by polymerizing furan and derivatives thereof, and pyrrole. And polypyrrole obtained by polymerizing thiophene and derivatives thereof, and polythiophene obtained by polymerizing derivatives thereof, among which polypyrrole is preferable.
π共役化合物を含む高分子は、原料単量体の酸化重合、電解重合、ラジカル重合、カップリング反応等、公知の製造方法により製造できる。また、該高分子の製造時には、公知の開始剤、重合時の安定性を高めるための添加剤、例えば、ポリアクリル酸、ポリビニルピロリドン、ポリビニルアルコールなどの分散安定剤やドデシル硫酸ナトリウム、臭化ヘキサデシルトリメチルアンモニウム、ポリオキシエチレンラウリルエーテルなどの界面活性剤等を適宜使用できる。これらを使用することで、π共役系化合物を主成分として形成された表面のさらに外側に、これらの分散安定剤、界面活性剤等からなる極薄い膜が形成される場合がある。このような製造工程に由来する薄膜は、実質的には、粒子の表面を形成しているものとは言えない。よって、本発明のイムノクロマト用着色粒子には、このような製造工程に由来する薄膜が結果的に最外表に形成されているものも含まれる。 A polymer containing a π-conjugated compound can be produced by a known production method such as oxidative polymerization, electrolytic polymerization, radical polymerization, or coupling reaction of raw material monomers. In addition, during the production of the polymer, known initiators, additives for increasing the stability during polymerization, such as dispersion stabilizers such as polyacrylic acid, polyvinylpyrrolidone, polyvinyl alcohol, sodium dodecyl sulfate, hexabromide Surfactants such as decyltrimethylammonium and polyoxyethylene lauryl ether can be appropriately used. By using these, an extremely thin film composed of these dispersion stabilizers, surfactants and the like may be formed on the outer side of the surface formed with the π-conjugated compound as a main component. It cannot be said that the thin film derived from such a manufacturing process substantially forms the particle surface. Therefore, the colored particles for immunochromatography of the present invention include those in which a thin film derived from such a production process is formed on the outermost surface as a result.
上記分散安定剤、界面活性剤の有無に関わらず、フェニル基及びスルホン酸塩を有する重合性単量体を存在させて、炭化水素系微粒子の表面をπ共役化合物を含む高分子で被覆させたイムノクロマト用着色粒子も本発明の1つである。 The surface of the hydrocarbon fine particle was coated with a polymer containing a π-conjugated compound in the presence of a polymerizable monomer having a phenyl group and a sulfonate regardless of the presence or absence of the dispersion stabilizer and the surfactant. Colored particles for immunochromatography are also one aspect of the present invention.
π共役化合物を含む高分子がポリピロールである場合、イムノクロマト用着色粒子の表面は一定の正荷電を有するが、該表面にフェニル基及びスルホン酸塩を有する重合性単量体を存在させることで、負荷電を有する着色粒子とすることができ、正荷電では不都合な抗原や抗体を結合させる際に好適に用いられる。また、フェニル基を有する成分が表面に一定割合で存在することになる為、適度な疎水性が与えられ、抗原や抗体の物理吸着に好都合な環境を付与できることも本発明の特徴の1つである。 When the polymer containing the π-conjugated compound is polypyrrole, the surface of the colored particles for immunochromatography has a certain positive charge, but by allowing a polymerizable monomer having a phenyl group and a sulfonate to exist on the surface, It can be used as a colored particle having negative charge, and is preferably used for binding an antigen or antibody which is not positively charged. In addition, since a component having a phenyl group is present on the surface in a certain ratio, it is one of the features of the present invention that moderate hydrophobicity is imparted and an environment favorable for physical adsorption of antigens and antibodies can be provided. is there.
本発明のイムノクロマト用着色粒子は、平均粒径が50〜1000nm、好ましくは、100〜500nmの粒子が用いられる。CV値(粒径の変動係数)は10%以下であることが好ましい。尚、CV値は、「粒径分布の標準偏差÷平均粒径×100」により算出される。着色粒子の平均粒径が50nm未満であると、視認性が劣り、1000nmを超えると、メンブレン中で目詰まりを起こす可能性が高まる。尚、本明細書における平均粒径とは、透過型電子顕微鏡により得られた任意の3視野における100個以上の粒子画像を画像解析装置を用いて解析して求めた値の平均値を示す。 The colored particles for immunochromatography of the present invention are particles having an average particle size of 50 to 1000 nm, preferably 100 to 500 nm. The CV value (particle size variation coefficient) is preferably 10% or less. The CV value is calculated by “standard deviation of particle size distribution ÷ average particle size × 100”. If the average particle diameter of the colored particles is less than 50 nm, the visibility is poor, and if it exceeds 1000 nm, the possibility of clogging in the membrane increases. In addition, the average particle diameter in this specification shows the average value of the value calculated | required by analyzing 100 or more particle | grain images in arbitrary three visual fields obtained with the transmission electron microscope using an image analyzer.
本発明のイムノクロマト用着色粒子の平均粒径は、例えば、粒径が一定の炭化水素系微粒子を用いる方法による制御、着色粒子合成時における分散安定剤による制御、乳化剤による制御、粒子電荷による制御、マイクロチャネル径による制御、撹拌操作による制御など、公知の方法により制御できるが、粒径が一定の炭化水素系微粒子を用いる方法が簡便で好ましい。尚、炭化水素系微粒子の粒径制御は、特開2003−510956号公報等に記載の方法で制御すればよく、例えば、重合開始剤の量を調整したり、重合温度を変化させるなどして、調整する方法が挙げられる。 The average particle size of the colored particles for immunochromatography of the present invention is, for example, controlled by a method using hydrocarbon fine particles having a constant particle size, controlled by a dispersion stabilizer during synthesis of colored particles, controlled by an emulsifier, controlled by particle charge, Although control by a known method such as control by microchannel diameter or control by stirring operation is possible, a method using hydrocarbon-based fine particles having a constant particle size is simple and preferable. The particle size control of the hydrocarbon-based fine particles may be controlled by the method described in JP-A No. 2003-51095, for example, by adjusting the amount of the polymerization initiator or changing the polymerization temperature. The method of adjusting is mentioned.
本発明のイムノクロマト用着色粒子を検出用担体として用いた診断用イムノクロマト試薬も本発明の1つである。診断用イムノクロマト試薬として用いられる項目は、例えば、インフルエンザウイルス、RSウイルス、アデノウイルス、ロタウイルス、ノロウイルス等が挙げられる。これらの項目に対応する抗体を本発明のイムノクロマト用着色粒子に結合させることで抗体感作粒子を作製し、イムノクロマト試薬とすることができる。結合の方法としては特に限定されず、従来公知の方法を用いることができ、例えば、抗原(または抗体)を含む緩衝液中にイムノクロマト用着色粒子を浸漬させ、一定温度で一定時間インキュベートするなどで物理吸着させる方法などが挙げられる。 A diagnostic immunochromatographic reagent using the colored particles for immunochromatography of the present invention as a detection carrier is also one aspect of the present invention. Examples of items used as diagnostic immunochromatography reagents include influenza virus, RS virus, adenovirus, rotavirus, norovirus and the like. Antibody-sensitized particles can be produced by binding antibodies corresponding to these items to the colored particles for immunochromatography of the present invention to obtain immunochromatographic reagents. The binding method is not particularly limited, and a conventionally known method can be used, for example, by immersing colored particles for immunochromatography in a buffer solution containing an antigen (or antibody) and incubating for a certain time at a certain temperature. Examples include a physical adsorption method.
また、本発明の診断用イムノクロマト試薬を用いれば、例えばイムノクロマトグラフ法の原理を用いた診断用テストストリップにおいて、移動層の液体中に抗体感作粒子を含浸させることによってコンジュゲートパッドに含有させ、メンブレン上に免疫反応部位として固定化した被検物質である抗原(または抗体)に対する抗体(または抗原)と結合、凝集させることによって、検体中の被検物質の存在を判定することができる。 In addition, if the diagnostic immunochromatographic reagent of the present invention is used, for example, in a diagnostic test strip using the principle of immunochromatography, it is contained in a conjugate pad by impregnating antibody-sensitized particles in the liquid of the moving layer, The presence of the test substance in the specimen can be determined by binding and agglutinating with an antibody (or antigen) against the antigen (or antibody) which is the test substance immobilized as an immune reaction site on the membrane.
以下、本発明について実施例を挙げて具体的に説明する。 Hereinafter, the present invention will be specifically described with reference to examples.
[炭化水素系微粒子1の作製]
4ツ口セパラブルカバー、攪拌翼、還流用冷却管、温度検出器、窒素導入管を取り付けた2000mL容のセパラブルフラスコに、脱イオン水1100g、スチレン(和光純薬製)170g、パラスチレンスルホン酸ナトリウム(東京化成製)0.08g、重合開始剤として過硫酸カリウム0.36g(和光純薬製)を秤量した後、210r.p.m.で攪拌しながら、容器内を窒素置換し、70℃で18時間重合を行った。
得られた白色溶液をペーパーろ紙でろ過、セルロースチューブにて透析精製(透析液:水、精製回数5回以上)し、目的の炭化水素系微粒子を得た(微粒子1とする)。得られた微粒子の粒径を透過型電子顕微鏡により粒径を測定したところ、301nm(CV6.0%)であった。
[Preparation of hydrocarbon fine particles 1]
In a 2000 mL separable flask equipped with a four-neck separable cover, a stirring blade, a reflux condenser, a temperature detector, and a nitrogen introduction tube, 1100 g of deionized water, 170 g of styrene (manufactured by Wako Pure Chemical Industries), and parastyrene sulfone After weighing 0.08 g of sodium acid (manufactured by Tokyo Chemical Industry) and 0.36 g of potassium persulfate (manufactured by Wako Pure Chemical Industries) as a polymerization initiator, 210 r. p. m. The inside of the container was purged with nitrogen while stirring, and polymerization was carried out at 70 ° C. for 18 hours.
The obtained white solution was filtered with a paper filter paper and purified by dialysis with a cellulose tube (dialysate: water, the number of purifications was 5 times or more) to obtain the desired hydrocarbon fine particles (referred to as fine particles 1). When the particle size of the obtained fine particles was measured with a transmission electron microscope, it was 301 nm (CV 6.0%).
[炭化水素系微粒子2の作製]
スチレン170gをスチレン100g、メタクリル酸メチル70gの混合物としたこと、及びパラスチレンスルホン酸ナトリウムを0.05gとしたこと以外は、炭化水素系微粒子1の方法と同様にして、目的の炭化水素系微粒子を得た(微粒子2とする)。上記と同様に粒径を測定したところ、得られた微粒子の粒径は、235nm(CV5.3%)であった。
[Preparation of hydrocarbon fine particles 2]
The target hydrocarbon fine particles are the same as the hydrocarbon fine particles 1 except that 170 g of styrene is a mixture of 100 g of styrene and 70 g of methyl methacrylate, and 0.05 g of sodium parastyrene sulfonate is used. (Referred to as fine particles 2). When the particle diameter was measured in the same manner as described above, the particle diameter of the obtained fine particles was 235 nm (CV 5.3%).
<実施例1>
4ツ口セパラブルカバー、攪拌翼、還流用冷却管、温度検出器、窒素導入管を取り付けた2000mL容のセパラブルフラスコに、脱イオン水700g、上述の微粒子1を10g、パラスチレンスルホン酸ナトリウム(東京化成製)20g、ピロール(和光純薬製)10gを秤量した後、210r.p.m.で攪拌しながら、容器内を窒素置換し、60℃に昇温した。
ついで、重合開始剤として過硫酸アンモニウム(和光純薬製)34.0gを脱イオン300gにて溶解させ、上記混合液中へ滴下した。滴下終了後更に8時間加熱攪拌させた後、冷却して反応を停止した。
遠心分離を行い、適度な脱イオン水を添加し、超音波洗浄機にて再分散させた。この操作を3回繰り返し、黒色着色粒子1を得た(ポリピロールによる着色粒子1)。透過型電子顕微鏡にて得られた粒子の粒径を測定したところ、368nm(CV6.4%)であった。
<Example 1>
In a 2000 mL separable flask equipped with a four-neck separable cover, stirring blade, reflux condenser, temperature detector, and nitrogen inlet tube, 700 g of deionized water, 10 g of the above-mentioned fine particles 1, and sodium parastyrenesulfonate After weighing 20 g (manufactured by Tokyo Chemical Industry) and 10 g of pyrrole (manufactured by Wako Pure Chemical Industries), 210 r. p. m. The inside of the container was purged with nitrogen while stirring, and the temperature was raised to 60 ° C.
Subsequently, 34.0 g of ammonium persulfate (manufactured by Wako Pure Chemical Industries, Ltd.) as a polymerization initiator was dissolved in 300 g of deionized and dropped into the mixed solution. After completion of the dropwise addition, the mixture was further heated and stirred for 8 hours, and then cooled to stop the reaction.
Centrifugation was performed, moderate deionized water was added, and the mixture was redispersed with an ultrasonic cleaner. This operation was repeated three times to obtain black colored particles 1 (colored particles 1 made of polypyrrole). It was 368 nm (CV6.4%) when the particle size of the particle | grains obtained with the transmission electron microscope was measured.
<実施例2>
使用したパラスチレンスルホン酸ナトリウムの量を10gに、ピロールの量を5gに変更し、過硫酸アンモニウムの量を17.0gに変更した以外は、ポリピロールによる着色粒子1の作製方法と同様にして黒色着色粒子を得た(ポリピロールによる着色粒子2)。上記と同様に得られた粒子の粒径を測定したところ、342nm(CV6.3%)であった。
<Example 2>
Black coloration in the same manner as for the production of colored particles 1 with polypyrrole, except that the amount of sodium parastyrenesulfonate used was changed to 10 g, the amount of pyrrole to 5 g, and the amount of ammonium persulfate to 17.0 g. Particles were obtained (colored particles 2 with polypyrrole). It was 342 nm (CV6.3%) when the particle size of the obtained particle | grains was measured similarly to the above.
<実施例3>
微粒子1を微粒子2に変更した以外は、ポリピロールによる着色粒子1の作製方法と同様にして黒色着色粒子を得た(ポリピロールによる着色粒子3)。上記と同様に得られた粒子の粒径を測定したところ、295nm(CV5.6%)であった。
<Example 3>
Black colored particles were obtained in the same manner as in the production method of the colored particles 1 made of polypyrrole except that the fine particles 1 were changed to the fine particles 2 (colored particles 3 made of polypyrrole). It was 295 nm (CV 5.6%) when the particle size of the obtained particle was measured in the same manner as described above.
<実施例4>
4ツ口セパラブルカバー、攪拌翼、還流用冷却管、温度検出器、窒素導入管を取り付けた2000mL容のセパラブルフラスコに、脱イオン水700g、上述の微粒子1を10g、ポリビニルピロリドン(K30、和光純薬製)10g、ピロール(和光純薬製)10gを秤量した後、210r.p.m.で攪拌しながら、容器内を窒素置換し、60℃に昇温した。
ついで、重合開始剤として過硫酸アンモニウム(和光純薬製)34.0gを脱イオン300gにて溶解させ、上記混合液中へ滴下した。滴下終了後更に8時間加熱攪拌させた後、冷却して反応を停止した。
遠心分離を行い、適度な脱イオン水を添加し、超音波洗浄機にて再分散させた。この操作を3回繰り返し、黒色着色粒子4を得た(ポリピロールによる着色粒子4)。透過型電子顕微鏡にて得られた粒子の粒径を測定したところ、335nm(CV6.3%)であった。
<Example 4>
In a 2000 mL separable flask equipped with a four-necked separable cover, a stirring blade, a reflux condenser, a temperature detector, and a nitrogen inlet tube, 700 g of deionized water, 10 g of the above-described fine particles 1, polyvinyl pyrrolidone (K30, After weighing 10 g of Wako Pure Chemical) and 10 g of pyrrole (Wako Pure Chemical), 210 r. p. m. The inside of the container was purged with nitrogen while stirring, and the temperature was raised to 60 ° C.
Subsequently, 34.0 g of ammonium persulfate (manufactured by Wako Pure Chemical Industries, Ltd.) as a polymerization initiator was dissolved in 300 g of deionized and dropped into the mixed solution. After completion of the dropwise addition, the mixture was further heated and stirred for 8 hours, and then cooled to stop the reaction.
Centrifugation was performed, moderate deionized water was added, and the mixture was redispersed with an ultrasonic cleaner. This operation was repeated three times to obtain black colored particles 4 (colored particles 4 made of polypyrrole). It was 335 nm (CV6.3%) when the particle size of the particle | grains obtained with the transmission electron microscope was measured.
<実施例5>
使用したピロールの量を5gに変更し、過硫酸アンモニウムの量を17.0gに変更した以外は、ポリピロールによる着色粒子4の作製方法と同様にして黒色着色粒子を得た(ポリピロールによる着色粒子5)。上記と同様に得られた粒子の粒径を測定したところ、323nm(CV6.2%)であった。
<Example 5>
Black colored particles were obtained in the same manner as the colored particle 4 production method except that the amount of pyrrole used was changed to 5 g and the amount of ammonium persulfate was changed to 17.0 g (colored particles 5 made of polypyrrole). . It was 323 nm (CV6.2%) when the particle size of the obtained particle | grains was measured similarly to the above.
<実施例6>
微粒子1を微粒子2に変更した以外は、ポリピロールによる着色粒子4の作製方法と同様にして黒色着色粒子を得た(ポリピロールによる着色粒子6)。上記と同様に得られた粒子の粒径を測定したところ、265nm(CV5.5%)であった。
<Example 6>
Black colored particles were obtained in the same manner as the colored particles 4 made of polypyrrole except that the fine particles 1 were changed to the fine particles 2 (colored particles 6 made of polypyrrole). When the particle size of the obtained particles was measured in the same manner as described above, it was 265 nm (CV 5.5%).
<比較例1>
[市販色素による着色粒子の作製1]
特開2003−202344号公報に記載の実施例1に従い、次のようにして着色粒子を作製した。
油溶性色素オイルブルー(オリエント化学工業製)2.4gをメタノール(和光純薬製)2000mLに溶解させた色素溶液を、固形量で6gとなるように採取した微粒子1の白色溶液を遠心分離(12000rpm)にて上清を廃棄したものの中に添加し、45℃で3日間過熱攪拌処理を行った(この際メタノールを徐々に蒸発させた)。次いで遠心分離を行い、メタノールを廃棄後、適度な脱イオン水を添加し、超音波洗浄機にて再分散させた。この操作を3回繰り返し、メタノールを完全に脱イオン水に置換した青色着色粒子を得た(市販色素による着色粒子1)。透過型電子顕微鏡にて粒径を測定したところ、325nm(CV6.8%)であった。
<Comparative Example 1>
[Preparation of colored particles from commercially available dyes 1]
According to Example 1 described in JP-A-2003-202344, colored particles were produced as follows.
Centrifugation of a white solution of fine particles 1 obtained by dissolving a dye solution in which 2.4 g of oil-soluble dye oil blue (manufactured by Orient Chemical Co., Ltd.) in 2000 mL of methanol (manufactured by Wako Pure Chemical Industries, Ltd.) to a solid amount of 6 g At 12000 rpm, the supernatant was added to the waste, and the mixture was heated and stirred at 45 ° C. for 3 days (in this case, methanol was gradually evaporated). Centrifugation was then performed, methanol was discarded, moderate deionized water was added, and redispersed with an ultrasonic cleaner. This operation was repeated three times to obtain blue colored particles in which methanol was completely replaced with deionized water (colored particles 1 with a commercially available dye). When the particle size was measured with a transmission electron microscope, it was 325 nm (CV 6.8%).
<比較例2>
[市販色素による着色粒子の作製2]
微粒子1を微粒子2に変更した以外は、市販色素による着色粒子1の作製方法と同様にして青色着色粒子を得た(市販色素による着色粒子2)。同様に粒径を測定したところ、254nm(CV5.9%)であった。
<Comparative example 2>
[Preparation of colored particles using commercially available dyes 2]
Blue colored particles were obtained in the same manner as the production method of the colored particles 1 with a commercially available dye except that the fine particles 1 were changed to the fine particles 2 (colored particles 2 with a commercially available dye). Similarly, the particle diameter was measured and found to be 254 nm (CV 5.9%).
[適用例]
<インフルエンザウィルス測定用イムノクロマト試薬の作製>
1.着色粒子標識抗A型インフルエンザウィルス抗体の調製
(1)2wt%着色粒子を含む20mM MES(pH6.5)緩衝液5mLに2.5mg/mL抗A型インフルエンザウィルスモノクロナール抗体を含む20mM MES(pH6.5)緩衝液を5mL添加し、室温で2時間攪拌した。その後、13,000rpmで10分間遠心分離し、上清を除去後、10%スクロース含有2%ウシ血清アルブミン(BSA)水溶液を10mL添加し、さらに2時間攪拌後、13,000rpmで10分間遠心分離し、抗体感作着色粒子を得た。その後、更に10%スクロース含有2%BSA水溶液を10mL添加し約1.0wt%着色粒子標識抗A型インフルエンザウィルス抗体(コンジュゲート)を得た。
[Application example]
<Preparation of immunochromatographic reagent for influenza virus measurement>
1. Preparation of colored particle-labeled anti-influenza A virus antibody (1) 20 mM MES containing 2.5 mg / mL anti-influenza A virus monoclonal antibody in 5 mL of 20 mM MES (pH 6.5) buffer containing 2 wt% colored particles (pH 6. 5) 5 mL of buffer solution was added and stirred at room temperature for 2 hours. Then, centrifuged at 13,000 rpm for 10 minutes, after removing the supernatant, 10 mL of 2% bovine serum albumin (BSA) aqueous solution containing 10% sucrose was added, and further stirred for 2 hours, then centrifuged at 13,000 rpm for 10 minutes, Antibody-sensitized colored particles were obtained. Thereafter, 10 mL of 2% BSA aqueous solution containing 10% sucrose was further added to obtain about 1.0 wt% colored particle-labeled anti-influenza A virus antibody (conjugate).
2.コンジュゲート塗布パッドの作製
上記1で調製したコンジュゲートを6.4 OD(λ650nm)/mLとなるように、0.5%カゼイン及び10%スクロース含有トリス緩衝液(pH8.5)と混合してコンジュゲート溶液を作製した。次に、グラスファイバー製パッド(Lydall社製)にイムノクロマトグラフ法用のディスペンサー「XYZ3050」(BIO DOT社製)を用いて該コンジュゲート溶液を10μl/cmで滲みこませた。その後、ドライオーブン内で70℃、30分間加温して乾燥させ、コンジュゲート塗布パッドとした。
2. Preparation of conjugate coating pad The conjugate prepared in 1 above was mixed with Tris buffer (pH 8.5) containing 0.5% casein and 10% sucrose so that the conjugate was 6.4 OD (λ650 nm) / mL. Produced. Next, the conjugate solution was soaked at 10 μl / cm into a glass fiber pad (manufactured by Lydall) using a dispenser “XYZ3050” (manufactured by BIO DOT) for immunochromatography. Then, it was heated and dried in a dry oven at 70 ° C. for 30 minutes to obtain a conjugate coating pad.
3.抗インフルエンザウィルス抗体固定化膜の作製
ニトロセルロース膜(Sartorius社製)に、0.75mg/mLに調製した前記着色粒子標識抗A型インフルエンザウィルス抗体とはエピトープを異にする抗A型インフルエンザウィルス抗体及び2.5%スクロースを含む10mMリン酸緩衝液(pH 7.2)を、幅約1mmのライン状に塗布した。塗布は、イムノクロマトグラフ法用のディスペンサー「XYZ3050」(BIO DOT社製)を用い、吐出量を1uL/cmとなるように設定した。ライン塗布後のニトロセルロース膜をドライオーブン内で70℃、45分間乾燥させ、抗インフルエンザウィルス抗体固定化膜とした。
3. Preparation of anti-influenza virus antibody-immobilized membrane A nitrocellulose membrane (manufactured by Sartorius), an anti-influenza A virus antibody having an epitope different from that of the colored particle-labeled anti-influenza A virus antibody prepared at 0.75 mg / mL and A 10 mM phosphate buffer (pH 7.2) containing 2.5% sucrose was applied in a line having a width of about 1 mm. For application, a dispenser “XYZ3050” (manufactured by BIO DOT) for immunochromatography was used, and the discharge amount was set to 1 uL / cm. The nitrocellulose film after the line coating was dried in a dry oven at 70 ° C. for 45 minutes to obtain an anti-influenza virus antibody-immobilized film.
4.テストストリップの作製
プラスチック製粘着シートに上記抗インフルエンザウィルス抗体固定化膜を貼り、上記2.で作製したコンジュゲート塗布パッドを配置装着し、反対側の端には吸収パッド(Whatman社製、740-E)を配置装着した。最後に、抗体固定化膜および吸収パッドを被覆するよ
うに上面にポリエステルフィルムを配置装着し、ラミネートした。このように各構成要素を重ね合わせた構造物を4mm幅に切断し、テストストリップを作成した。該テストストリ
ップの寸法は、4mm×98mm(幅×長さ)であり、イムノクロマトテストストリップの形態
にした。
4). Preparation of test strip The anti-influenza virus antibody-immobilized membrane is attached to a plastic pressure-sensitive adhesive sheet, and 2. The conjugate application pad prepared in 1 was placed and mounted, and an absorbent pad (Whatman, 740-E) was placed and mounted on the opposite end. Finally, a polyester film was placed on the upper surface so as to cover the antibody-immobilized membrane and the absorption pad, and laminated. In this way, the structure in which the respective constituent elements were overlapped was cut to a width of 4 mm to prepare a test strip. The dimensions of the test strip were 4 mm × 98 mm (width × length) and were in the form of an immunochromatographic test strip.
5.検体抽出液及び感度確認用サンプルの調製
200mM 塩化カリウム、150mM L-アルギニン、0.5% Brij35、0.25% BSA、及び0.05% プロクリン(登録商標)950を含む50mM トリス緩衝液(pH8.5)を検体抽出液とした。また、A型インフルエンザウィルス標準液を検体抽出液で段階希釈し、感度確認用サンプルとした。
5. Preparation of sample extract and sensitivity confirmation sample
The specimen extract was 50 mM Tris buffer (pH 8.5) containing 200 mM potassium chloride, 150 mM L-arginine, 0.5% Brij35, 0.25% BSA, and 0.05% Procrine (registered trademark) 950. In addition, a type A influenza virus standard solution was serially diluted with a specimen extract to obtain a sample for sensitivity confirmation.
6.発色強度測定
感度確認用サンプルに上記4.で作製したテストストリップを浸し、10分後にラインの
発色強度を測定した(表1)。発色強度測定には、青の発色見本から0.25単位で数値をつけたカラーチャート(0.25〜4.0)を用い、n=3の平均値をその感度確認用サンプルにおける発色強度とした。尚、黒色粒子の場合は、青の発色見本と同程度の濃さとなる発色見本を別途作製し、同様の評価を行った。発色強度はその数値が高いほど感度が高く、0.5以上が目視による検出が可能である。
6). Color intensity measurement The test strip prepared in 4 above was immersed in a sample for confirmation of sensitivity, and the color intensity of the line was measured 10 minutes later (Table 1). For the color intensity measurement, a color chart (0.25 to 4.0) with a value of 0.25 unit from the blue color sample was used, and the average value of n = 3 was defined as the color intensity of the sensitivity confirmation sample. In the case of black particles, a color development sample having a darkness similar to that of the blue color development sample was separately prepared and subjected to the same evaluation. The higher the numerical value, the higher the sensitivity, and 0.5 or higher is visually detectable.
表1の評価によれば、炭化水素系微粒子の表面にπ共役化合物を含む高分子を被覆させることで、同じ炭化水素系微粒子の表面にπ共役化合物を含まない着色粒子と比較して、より濃色化され視認性に優れた着色粒子が得られることがわかる。 According to the evaluation in Table 1, by coating the surface of the hydrocarbon-based fine particles with a polymer containing a π-conjugated compound, the surface of the same hydrocarbon-based fine particles can be compared with colored particles that do not include the π-conjugated compound. It can be seen that colored particles having a deep color and excellent visibility can be obtained.
本発明によれば、粒子表面を形成する組成自身が着色性を示すことで、ラテックス粒子の表面組成を維持し、濃い色調を示すことができるイムノクロマト用着色粒子が得られることから、従来より濃色化が図れる視認性の優れたイムノクロマト用着色粒子、及び該粒子を用いたイムノクロマト試薬を提供できる。 According to the present invention, colored particles for immunochromatography that can maintain the surface composition of latex particles and exhibit a deep color tone can be obtained because the composition itself that forms the surface of the particles exhibits colorability, so that it is darker than before. Colored particles for immunochromatography that can be colored and have excellent visibility, and immunochromatographic reagents using the particles can be provided.
Claims (9)
・フェニル基を有する重合性単量体
・メタクリロイル基を有する重合性単量体
・アクリロイル基を有する重合性単量体
からなる群から選ばれる一種類以上と、
・フェニル基及びスルホン酸塩を有する重合性単量体
を共重合させたことを特徴とする請求項3または4に記載のイムノクロマト用着色粒子。 Hydrocarbon fine particles
One or more kinds selected from the group consisting of a polymerizable monomer having a phenyl group, a polymerizable monomer having a methacryloyl group, a polymerizable monomer having an acryloyl group,
The colored particles for immunochromatography according to claim 3 or 4, wherein a polymerizable monomer having a phenyl group and a sulfonate is copolymerized.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014072583A JP6420055B2 (en) | 2013-03-29 | 2014-03-31 | Colored particles for immunochromatography and diagnostic immunochromatography reagent using the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013074493 | 2013-03-29 | ||
JP2013074493 | 2013-03-29 | ||
JP2014072583A JP6420055B2 (en) | 2013-03-29 | 2014-03-31 | Colored particles for immunochromatography and diagnostic immunochromatography reagent using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014209117A true JP2014209117A (en) | 2014-11-06 |
JP6420055B2 JP6420055B2 (en) | 2018-11-07 |
Family
ID=51903403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014072583A Active JP6420055B2 (en) | 2013-03-29 | 2014-03-31 | Colored particles for immunochromatography and diagnostic immunochromatography reagent using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6420055B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102347808B1 (en) * | 2020-12-03 | 2022-01-07 | 연세대학교 산학협력단 | Complexes for detecting viruses based conjugated polymer |
CN114410751A (en) * | 2021-12-30 | 2022-04-29 | 安徽科技学院 | Marker nucleic acid probe, preparation method thereof, test strip and application of polypyrrole nano particles |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034150A1 (en) * | 1996-03-14 | 1997-09-18 | Abbott Laboratories | Binding members extending from particles for immunoassay |
JPH10206428A (en) * | 1996-10-30 | 1998-08-07 | Sekisui Chem Co Ltd | Colored latex |
JP2000512750A (en) * | 1996-06-07 | 2000-09-26 | アボツト・ラボラトリーズ | Methods for improving the performance of immunoreagents in immunoassays |
WO2004025300A1 (en) * | 2002-09-13 | 2004-03-25 | Hitachi Chemical Co., Ltd. | Fixation carrier and solid phase |
JP2008003083A (en) * | 1997-05-16 | 2008-01-10 | Abbott Lab | Magnetically assisted binding assay utilizing magnetically responsive reagent |
US20080085566A1 (en) * | 2006-10-05 | 2008-04-10 | Massachusetts Institute Of Technology | Emissive compositions with internal standard and related techniques |
-
2014
- 2014-03-31 JP JP2014072583A patent/JP6420055B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034150A1 (en) * | 1996-03-14 | 1997-09-18 | Abbott Laboratories | Binding members extending from particles for immunoassay |
JP2000512750A (en) * | 1996-06-07 | 2000-09-26 | アボツト・ラボラトリーズ | Methods for improving the performance of immunoreagents in immunoassays |
JPH10206428A (en) * | 1996-10-30 | 1998-08-07 | Sekisui Chem Co Ltd | Colored latex |
JP2008003083A (en) * | 1997-05-16 | 2008-01-10 | Abbott Lab | Magnetically assisted binding assay utilizing magnetically responsive reagent |
WO2004025300A1 (en) * | 2002-09-13 | 2004-03-25 | Hitachi Chemical Co., Ltd. | Fixation carrier and solid phase |
US20080085566A1 (en) * | 2006-10-05 | 2008-04-10 | Massachusetts Institute Of Technology | Emissive compositions with internal standard and related techniques |
Non-Patent Citations (3)
Title |
---|
LE, H.Q.A. ET AL.: "Investigation of SPR and electrochemical detection of antigen with polypyrrole functionalized by bio", ANALYTICA CHIMICA ACTA, vol. 674, JPN6018036505, 16 June 2010 (2010-06-16), pages 1 - 8, ISSN: 0003880869 * |
TARCHA, P.J. ET AL.: "Synthesis, Analysis, and Immunodiagnostic Applications of Polypyrrole Latex and Its Derivatives", ACM SYMPOSIUM SERIES, vol. 492, JPN6018036504, 1992, pages 347 - 367, ISSN: 0003880868 * |
馬場暁 他: "透過型表面プラズモン共鳴法によるポリピロール誘導体薄膜上ヒトIgGの検出", 電子情報通信学会技術研究報告, vol. 110, no. 409, JPN6018036506, 31 January 2011 (2011-01-31), JP, pages 1 - 4, ISSN: 0003880870 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102347808B1 (en) * | 2020-12-03 | 2022-01-07 | 연세대학교 산학협력단 | Complexes for detecting viruses based conjugated polymer |
CN114410751A (en) * | 2021-12-30 | 2022-04-29 | 安徽科技学院 | Marker nucleic acid probe, preparation method thereof, test strip and application of polypyrrole nano particles |
CN114410751B (en) * | 2021-12-30 | 2024-01-12 | 安徽科技学院 | Marker nucleic acid probe, preparation method thereof, test strip and application of polypyrrole nano particle |
Also Published As
Publication number | Publication date |
---|---|
JP6420055B2 (en) | 2018-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5283079A (en) | Process to make magnetically responsive fluorescent polymer particles | |
JP6348239B1 (en) | Analyte concentration measurement method, aggregated fluorescent material-containing particles, and inspection device | |
US5395688A (en) | Magnetically responsive fluorescent polymer particles | |
US6013531A (en) | Method to use fluorescent magnetic polymer particles as markers in an immunoassay | |
CA2046894C (en) | Magnetically responsive fluorescent polymer particles and application thereof | |
WO2018043687A2 (en) | Fluorescent particles for diagnostic agent and immunoassay reagent using same | |
US9939433B2 (en) | Latex particles for measuring particle agglutination | |
JP6320711B2 (en) | Colored latex particles for diagnostic agents containing oil-soluble dyes | |
US9465033B2 (en) | Latex particles for agglutination assay | |
KR102013464B1 (en) | Latex particle for measurement reagent, sensitized latex particle, and measurement reagent for immunonephelometry | |
JP6420055B2 (en) | Colored particles for immunochromatography and diagnostic immunochromatography reagent using the same | |
JP4935973B2 (en) | Organic polymer particles and method for producing the same | |
JP2017040631A (en) | Composite particle and method for producing the same | |
JP2018146535A (en) | Method of manufacturing probe binding carrier, method of detecting or isolating target substance, probe binding carrier, and protein or nucleic acid stabilizer | |
JP7034089B2 (en) | Colored latex particles and reagents for immunoassay using them | |
US9383356B2 (en) | Latex particles for particle agglutination assay | |
JP4249464B2 (en) | Colored latex | |
JP2006145256A (en) | Magnetic material included particles for immunoassay and immunochromatography method | |
JP2001021560A (en) | Immunity chromatography | |
JPS5944660A (en) | Analytical element for immunoassay | |
JP6293983B2 (en) | Polymeric fine particles having microphase-separated structured particles, reagent for particle immunoassay using the same, and particle immunoassay | |
JP2002148264A (en) | Labeled complex and immunoassay method | |
JP2006189268A (en) | Magnetic particle for diagnostic drug | |
JP2001091515A (en) | Labeled specific combination body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A625 | Written request for application examination (by other person) |
Free format text: JAPANESE INTERMEDIATE CODE: A625 Effective date: 20170313 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180409 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180919 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181011 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6420055 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |